Mosaic Co (MOS) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is facing multiple headwinds, including weak financial performance, negative analyst sentiment, and challenging market conditions. While there are no strong positive catalysts, the technical indicators and options data suggest a lack of bullish momentum. It is better to wait for clearer signs of recovery or improvement in fundamentals before considering an investment.
The technical indicators for MOS are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 30.152, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 26.014), but there is no clear signal for a reversal.

Scotiabank's recent upgrade to Outperform with a $36 price target, citing potential recovery in phosphate margins and improved fundamentals in the long term.
Recent downgrades from Barclays, JPMorgan, and Oppenheimer, citing high input costs, lower phosphate prices, and negative earnings momentum.
U.S. Department of Justice investigation into fertilizer manufacturers, which could impact Mosaic's market position.
Weak financial performance in Q4 2025, with a significant net income loss and declining EPS.
In Q4 2025, Mosaic reported a revenue increase of 5.60% YoY to $2.97 billion. However, net income dropped significantly to -$519.5 million (-407.40% YoY), and EPS fell to -1.64 (-409.43% YoY). Gross margin improved slightly to 11.52%, up 7.46% YoY, but overall profitability remains under pressure.
Analyst sentiment is mixed to negative. Barclays downgraded the stock to Equal Weight, and JPMorgan downgraded it to Underweight, citing high costs and negative earnings momentum. Scotiabank upgraded the stock to Outperform, but the price target was lowered by several firms, reflecting cautious optimism at best.